Historical perspective on hormonal therapy of advanced breast cancer.
about
Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolismRelative expression analysis for molecular cancer diagnosis and prognosisLeishmania is not prone to develop resistance to tamoxifen.The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer.The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin.Breast cancer: beyond the cutting edge.Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancer.Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.ERα17p, an ERα P295 -T311 fragment, modifies the migration of breast cancer cells, through actin cytoskeleton rearrangements.The estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.Long-term remission of hormone receptor-positive/HER2-positive metastatic breast cancer due to combined treatment with everolimus/trastuzumab/exemestane: A case report.Comparative efficacy of extracts from Lycium barbarum bark and fruit on estrogen receptor positive human mammary carcinoma MCF-7 cells.
P2860
Q28241653-17BF8EE5-9712-4C60-BFA0-EA0D699D56EFQ34066558-BED394CD-62BC-49EB-9919-F19784FE39C3Q35801671-5481369A-6307-4260-9E1F-C9A89E37AEBAQ36195219-41897588-DE27-4FBE-81B4-A235BF5412A6Q36904898-C06F45A7-EF3E-4B77-8004-A29493484658Q37036957-8E2B03F1-B47D-47AA-B1B5-3963649AA787Q37598890-24A0D206-4BD1-41ED-BE6A-A8656AB539B7Q37655166-BC01BD10-15E2-46D5-B991-0904EAD04158Q37915362-857ED1D1-BAA2-4C63-A766-C9184DC6CDC0Q39183133-21970B8E-962A-49B3-B81E-C5C3251386A1Q39492980-1E6127F8-7352-4A72-9976-B64EE9FA7295Q39619285-6C41202C-9559-40CB-AEB0-E72D2C12778AQ41142443-E332C191-128D-4C82-BCFE-1B3F388AB179Q46718023-22A1C85A-0F93-46AD-81C9-5A7A697ABDA5
P2860
Historical perspective on hormonal therapy of advanced breast cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Historical perspective on hormonal therapy of advanced breast cancer.
@ast
Historical perspective on hormonal therapy of advanced breast cancer.
@en
Historical perspective on hormonal therapy of advanced breast cancer.
@nl
type
label
Historical perspective on hormonal therapy of advanced breast cancer.
@ast
Historical perspective on hormonal therapy of advanced breast cancer.
@en
Historical perspective on hormonal therapy of advanced breast cancer.
@nl
prefLabel
Historical perspective on hormonal therapy of advanced breast cancer.
@ast
Historical perspective on hormonal therapy of advanced breast cancer.
@en
Historical perspective on hormonal therapy of advanced breast cancer.
@nl
P1476
Historical perspective on hormonal therapy of advanced breast cancer.
@en
P2093
Craig Jordan
P356
10.1016/S0149-2918(02)85031-7
P478
24 Suppl A
P577
2002-01-01T00:00:00Z